Skip to main content

Antimicrobial Drug Resistance

Clinical and Epidemiological Aspects, Volume 2

  • Book
  • © 2009

Overview

Part of the book series: Infectious Disease (ID)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (45 chapters)

  1. Gram-Positive Bacterial Drug Resistance – Clinical

  2. Gram-Negative Bacterial Drug Resistance – Clinical

  3. Fungal Drug Resistance – Clinical

Keywords

About this book

This ? rst edition of Antimicrobial Drug Resistance grew out of a desire by the editors and authors to have a comprehensive resource of information on antimicrobial drug resistance that encompassed the current information available for bacteria, fungi, protozoa and viruses. We believe that this information will be of value to clinicians, epidemiologists, microbiologists, virologists, parasitologists, public health authorities, medical students and fellows in training. We have endeavored to provide this information in a style which would be accessible to the broad community of persons who are concerned with the impact of drug resistance in our cl- ics and across the broader global communities. Antimicrobial Drug Resistance is divided into Volume 1 which has sections covering a general overview of drug resistance and mechanisms of drug resistance ? rst for classes of drugs and then by individual microbial agents including bacteria, fungi, protozoa and viruses. Volume 2 addresses clinical, epidemiologic and public health aspects of drug resistance along with an overview of the conduct and interpretation of speci? c drug resistance assays. Together, these two volumes offer a comprehensive source of information on drug resistance issues by the experts in each topic.

Reviews

From the reviews:

“This book is a comprehensive guide to the state of the field as far as clinical practice is concerned. … There is good coverage of the wider spectrum of pathogens: viruses, fungi and parasites are addressed as well as bacterial infections. Each contribution is exhaustive and will appeal very much to the clinical microbiologist and infectious disease specialist. … This is certainly a reference book, and every diagnostic laboratory would derive value in having a copy on its shelves.” (Colin Howard, Microbiology Today, June, 2010)

Editors and Affiliations

  • Executive Vice President & Chief Medical Officer, Idenix Pharmaceuticals, Cambridge, USA

    Douglas L. Mayers

Bibliographic Information

  • Book Title: Antimicrobial Drug Resistance

  • Book Subtitle: Clinical and Epidemiological Aspects, Volume 2

  • Editors: Douglas L. Mayers

  • Series Title: Infectious Disease

  • DOI: https://doi.org/10.1007/978-1-60327-595-8

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Humana Press 2009

  • Hardcover ISBN: 978-1-60327-594-1Published: 20 July 2009

  • Softcover ISBN: 978-1-4939-6152-8Published: 23 August 2016

  • eBook ISBN: 978-1-60327-595-8Published: 14 July 2009

  • Edition Number: 1

  • Number of Pages: XXVI, 692

  • Topics: Infectious Diseases

Publish with us